Lung cancer treatments within the Asian community in the U.S. were found to vary based on their ethnicity, culture and gender preferences, reveals a new study.
The study was from the University of Southern California, Keck School of Medicine. The research team sought to examine possible health disparities in the treatment of lung cancer within the Asian community in the U.S.
Lung Cancer
Lung cancer is a malignant tumor in the lung tissues. Smoking is the main cause of lung cancer with symptoms like recurrent respiratory diseases.
Advertisement
‘Lung cancer treatments among Asian ethnicities vary widely, and cultural and gender preferences appear to exist for different modalities of care.’
Read More..
Tweet it Now
Read More..
In this study, rates of recommended care for non-small cell lung cancer were compared among patients in the Asian community.
The authors concluded that practice patterns within different Asian ethnicities vary widely, and cultural and gender preferences appear to exist for different modalities of care.
![Lung Cancer Screening]( "Lung Cancer Screening")
Lung cancer accounts for nearly 1.3 million deaths annually worldwide. Lung cancer screening can help in early detection of cancer and possible cure.
Using the American College of Surgeons' National Cancer Database, researchers examined the records of nearly 19,000 Asian patients of various ethnic origins and the treatment they received after their diagnosis of non-small cell lung cancer.
The authors found that Chinese, Indian and Korean patients were more likely to receive surgery and chemotherapy, but not radiation when compared with white patients.
Japanese patients were more likely to receive surgery, but less likely to undergo chemotherapy. Filipino patients were more likely to undergo chemotherapy, but not radiation. Women were more likely than men to receive surgery and chemotherapy, but not radiation.
"Our study shows the differences in care to different Asian ethnicities and that targeted interventions need to be tailored to gender and ethnicity to reduce Asian lung cancer disparities," states Dr. Alex Balekian, lead researcher.
Source: Eurekalert
Lung Cancer Screening
Lung cancer accounts for nearly 1.3 million deaths annually worldwide. Lung cancer screening can help in early detection of cancer and possible cure.
Advertisement
Using the American College of Surgeons' National Cancer Database, researchers examined the records of nearly 19,000 Asian patients of various ethnic origins and the treatment they received after their diagnosis of non-small cell lung cancer.
The authors found that Chinese, Indian and Korean patients were more likely to receive surgery and chemotherapy, but not radiation when compared with white patients.
Japanese patients were more likely to receive surgery, but less likely to undergo chemotherapy. Filipino patients were more likely to undergo chemotherapy, but not radiation. Women were more likely than men to receive surgery and chemotherapy, but not radiation.
"Our study shows the differences in care to different Asian ethnicities and that targeted interventions need to be tailored to gender and ethnicity to reduce Asian lung cancer disparities," states Dr. Alex Balekian, lead researcher.
Source: Eurekalert
Lung Cancer Awareness Month - Improving Lung Cancer Survival
Lung cancer awareness month is observed in November and aims to educate the general public about lung cancer and improve survival. Lung cancer is the most common cancer in men and the third most common cancer in women.
Advertisement
 Lung Cancer Mortality Rates Among Women May Increase to 40% by 2030Lung and breast cancers could cause more deaths among women in high-income countries compared to middle-income countries by 2030, says study. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
